Can Oral Mucosal Delivery Unlock Cannabinoid Medicine’s Potential?
Oral mucosal cannabinoid absorption offers a promising alternative to traditional oral ingestion by bypassing hepatic metabolism. This method enhances bioavailability and may improve therapeutic consistency. Understanding these delivery systems is…
Cannabinoid Pain Relief: Evidence-Based Clinical Guide
Clinical Takeaway Cannabinoids modulate pain signaling by affecting sodium channels involved in nerve impulse transmission, with preclinical evidence showing reduced pain-related neuronal activity. Current research demonstrates that cannabinoid…
Understanding Cannabidiol Supplement Use and WADA Drug Testing Results
Cannabidiol supplements and WADA-prohibited cannabinoids pose doping risks for athletes. Broad-spectrum CBD products can lead to positive anti-doping tests due to trace cannabinoids. Athletes should prefer CBD isolate to avoid unintended WADA violations.
Exploring Minor Cannabinoids and Terpenes in Cannabis Therapy
Minor cannabinoids and terpenes play a crucial role in the entourage effect by physically binding to cannabinoid receptors. This interaction may enhance therapeutic outcomes beyond isolated compounds. Understanding minor cannabinoids and terpenes helps…
Cannabinoids and Pain: Pharmacology and Clinical Evidence
Cannabinoid pharmacology pain management is critical for understanding medical cannabis use in chronic pain. This review synthesizes mechanisms, dosing, and clinical evidence. Clinicians benefit from educational resources bridging patient demand and…
Cannabinoid Pain Relief: Sodium Channel Modulation Research
Clinical Takeaway Cannabinoids modulate pain signaling by affecting sodium channels involved in nerve transmission, based on laboratory evidence from multiple studies. This mechanism may explain part of cannabinoids' pain-relieving effects, though…
Cannabis Use Patterns and Acute Pain Perception During Brief Abstinence
This clinical study investigates acute pain cannabinoid withdrawal during brief cannabis abstinence. It reveals sex-dependent differences linked to circulating cannabinoid levels. Understanding these patterns aids personalized pain management strategies.
Can CBD Gummies Make You Depressed? Insights from Pathologica
CBD depression drug safety dosing is a critical topic for clinicians and patients alike. Current evidence shows mixed effects of CBD on mood, requiring careful monitoring. Understanding dosing and product quality is essential to avoid worsening…
Cannabis Meets Drug Metabolism: What We Know—and Don’t Know—About Cannabinoids and CYP450 Enzymes
The cannabinoid drug interactions clinical evidence review highlights how cannabinoids like CBD and THC can modulate CYP450 enzymes. This modulation may alter the metabolism of many prescription drugs, raising safety concerns. Understanding these…
Assessing Evoked and Spontaneous Pain with Gabapentin and CB2 Receptor Activation
This study investigates neuropathic pain CB2 receptor activation and gabapentin effects on evoked and spontaneous pain. Using a spared nerve injury model, researchers compared pain responses in rats. Findings highlight potential cannabinoid mechanisms…